All News #Library
Biotech
Biosyngen`s CAR-T Asset for Solid Tumors Enters Phase II, Data Debut at ESMO
18 Sep 2024 //
PR NEWSWIRE
Biosyngen`s BRG01 Receives FDA Approval for Phase II Clinical Trial
12 Aug 2024 //
PR NEWSWIRE
Biosyngen partners with Singapore`s A*STAR to advance autoimmune therapy
02 Aug 2024 //
BIOSPECTRUM ASIA
Biosyngen`s BST02 is Granted an IND Approval by FDA
26 Oct 2023 //
PR NEWSWIRE
Biosyngen received the APCGTEA 2023
18 Sep 2023 //
PR NEWSWIRE

Market Place
Sourcing Support